Therapeutic Expertise

Robust Experience in Healthcare

Our therapeutic area expertise spans many drug disease markets including but not limited to expertise in growing areas such as oncology, rare disease, biosimilars, companion diagnostics, and cell and gene therapy

Oncology

At Amplity Health, we understand that every Oncology launch is uniquely complex. Our holistic, flexible solutions are designed to address challenges or gaps at every phase of the lifecycle on a global scale.

View our case studies below to see how we’ve successfully partnered with pharma by co-creating the support systems needed to be successful in complex Oncology launches.

Rare Disease

On average, a Rare Disease patient may see doctors for five years before reaching a diagnosis. The rare disease community deserves the same resilience from healthcare providers that they bring to each new day. Amplity Health is committed to partnering with pharma active in the Rare Disease space from engagement, education, and advocacy to testing, diagnosis, and treatment:

Patient engagement and advocacy
Key Opinion Leader (KOL) and medical community network building
Understanding Patient and Physician challenges
Disease education
Scientific exchange of disease information with Healthcare Providers (HCPs)
HCP community building for referral networks
Genetic/Diagnostic testing capability and execution
Patient identification and support services triaging
Cross-functional partnership for testing pull-through

Read our case studies below to see how we’ve partnered with pharma to co-create solutions that ensure Rare Disease patients gain access to and benefit from the best medicine for the right reasons.

Case Studies

Amplity provides the expertise you need at every stage of the drug development process to plan and execute your plan with skill, precision, and unwavering focus on quality. Please see our case studies below.

Commercial Solutions

Remote Engagement

Capability Development

Ready to discuss how we can partner to create better healthcare solutions?